Kazhan Mollazadegan
PhD student at Department of Medical Sciences; Endocrine Tumour Biology
- E-mail:
- kazhan.mollazadegan@medsci.uu.se
- Visiting address:
- Akademiska sjukhuset, ingång 40, 5 tr
751 85 UPPSALA - Postal address:
- Akademiska sjukhuset, ingång 40, 5 tr
751 85 UPPSALA
Publications
Recent publications
-
The impact of re-characterizing metastatic pancreatic neuroendocrine tumors: A prospective study
Part of Journal of neuroendocrinology, 2025
- DOI for The impact of re-characterizing metastatic pancreatic neuroendocrine tumors: A prospective study
- Download full text (pdf) of The impact of re-characterizing metastatic pancreatic neuroendocrine tumors: A prospective study
-
Part of Journal of Pathology, p. 357-370, 2024
- DOI for The evolutionary history of metastatic pancreatic neuroendocrine tumours reveals a therapy driven route to high-grade transformation
- Download full text (pdf) of The evolutionary history of metastatic pancreatic neuroendocrine tumours reveals a therapy driven route to high-grade transformation
-
Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors
Part of Upsala Journal of Medical Sciences, 2024
- DOI for Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors
- Download full text (pdf) of Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors
-
Part of Endocrine-Related Cancer, 2024
-
Risk of complications after core needle biopsy in pheochromocytoma/paraganglioma
Part of Endocrine-Related Cancer, 2023
- DOI for Risk of complications after core needle biopsy in pheochromocytoma/paraganglioma
- Download full text (pdf) of Risk of complications after core needle biopsy in pheochromocytoma/paraganglioma
All publications
Articles in journal
-
The impact of re-characterizing metastatic pancreatic neuroendocrine tumors: A prospective study
Part of Journal of neuroendocrinology, 2025
- DOI for The impact of re-characterizing metastatic pancreatic neuroendocrine tumors: A prospective study
- Download full text (pdf) of The impact of re-characterizing metastatic pancreatic neuroendocrine tumors: A prospective study
-
Part of Journal of Pathology, p. 357-370, 2024
- DOI for The evolutionary history of metastatic pancreatic neuroendocrine tumours reveals a therapy driven route to high-grade transformation
- Download full text (pdf) of The evolutionary history of metastatic pancreatic neuroendocrine tumours reveals a therapy driven route to high-grade transformation
-
Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors
Part of Upsala Journal of Medical Sciences, 2024
- DOI for Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors
- Download full text (pdf) of Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors
-
Part of Endocrine-Related Cancer, 2024
-
Risk of complications after core needle biopsy in pheochromocytoma/paraganglioma
Part of Endocrine-Related Cancer, 2023
- DOI for Risk of complications after core needle biopsy in pheochromocytoma/paraganglioma
- Download full text (pdf) of Risk of complications after core needle biopsy in pheochromocytoma/paraganglioma
-
Poor outcome after systemic therapy in secondary high-grade pancreatic neuroendocrine tumors
Part of Endocrine Connections, 2022
- DOI for Poor outcome after systemic therapy in secondary high-grade pancreatic neuroendocrine tumors
- Download full text (pdf) of Poor outcome after systemic therapy in secondary high-grade pancreatic neuroendocrine tumors